Plasma Derived from Therapeutic Plasma Exchange
Detailed guidance document from FDA and regulatory agencies.
Document Details
Memorandum
December 14, 1984
July 16, 2020
83d64ec6-ba80-482f-a450-aac3b802f645
Related Documents
Volume Limits for Automated Collection of Source Plasma
MemorandumNovember 4, 1992Center for Biologics Evaluation and Research
Revised Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV)
MemorandumAugust 5, 1993Center for Biologics Evaluation and Research
Donor Deferral Due to Red Blood Cell Loss During Collection of Source Plasma by Automated Plasmapheresis
MemorandumDecember 4, 1995Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.